Advertisement|Remove ads.

Firefly Neuroscience Inc. (AIFF) announced on Thursday an agreement with the Department of War to deploy its artificial intelligence-driven EEG/ERP platform for evaluating and treating active-duty personnel and veterans affected by PTSD and traumatic brain injuries.
The initiative focuses on using advanced brain-monitoring technology to address persistent challenges tied to military health.
The effort builds on earlier research conducted with a U.S. Naval Medical Center program, laying the groundwork for broader adoption across military healthcare systems.
Following the update, Firefly Neuroscience stock traded over 20% in Thursday’s premarket.
Get updates to this developing story directly on Stocktwits.